Department of Oncology, 2nd Faculty of Medicine, Charles University in Prague and Motol University Hospital
Introduction to Complex Oncological Centers
The committee of the Czech Oncological Society ČLS JEP (ČOS) discussed applications from medical facilities to acquire the status of a complex oncological center (KOC) or a complex oncological group (KOS) on the basis of the declared criteria. A basic network of 18 workplaces was selected, in which the Czech Oncological Society guarantees the assurance of comprehensive care in the area of diagnosis and treatment of tumorous diseases to patients starting from January 1, 2006. However, this does not mean that patients will be treated only at these departmenrs. The existing oncological and radiotherapeutic departments in smaller towns will become inseparable parts of this network as well. Creating regional networks is fully within the competence of the individual accredited departments.
Complex Oncological Center of the University Hospital Motol
The radiotherapeutic-oncological department of the University Hospital Motol performs full treatment of tumorous diseases through radiotherapy, chemotherapy, hormonal and biological treatment, and also provides treatment of symptoms. A combination of several treatment procedures is required very often, and therefore the radiotherapeutic-oncological department closely cooperates with other departments and clinics of the University Hospital Motol, as well as with other hospitals.
Equipment and methods utilized
We use linear accelerators for external therapy, and an irradiation device with the high-activity radionuclide radiation source Iridium 192 for brachytherapy. The majority of external radiotherapy takes the form of conform radical therapy, although palliative radiotherapy also plays a part. In addition to these methods, we perform special operations such as irradiation of child patients, total body irradiation for children and stereotactical irradiation of the brain. We have introduced the methods of IGRT – image-guided radiotherapy, and IMRT – intensity modulated radiotherapy.
We perform an application of anti-cancer chemotherapy, including preparation for high-dose chemotherapy, application of locoregional chemotherapy and concomitant treatment with radiotherapy in the area of clinical oncology. We apply continuous chemotherapy.
Cooperation in education
Our department is an instructional workplace for the 2nd Faculty of Medicine of Charles University and for the Nuclear and Physical-Engineering School of ČVUT. We cooperate with the International Atomic Agency in the training of foreign doctors and physicists in the field of radiotherapy.
We take part in a number of clinical studies of type II and III with international participation. After patients express their consent, they are included in a clinical research using new cytostatics and biological treatments.
Membership in expert groups
Our department is a member of the Czech Lymphoma Study Group (CLSG), within which we participate in a number of international clinical studies led by other national centers (e.g., German Lymphoma Group, French Lymphoma Group). We are also a member of the Czech Myeloma Group (CMG) for the treatment of multiple myeloma.
Participation in meetings and conferences
Patients with rare tumors for which experience in the Czech Republic is insufficient are referred to specialized European centers. Doctors from our department regularly attend national and international expert meetings, where they present their treatment results and have the opportunity to exchange their experience and acquire new knowledge in their profession.
Providing high-quality oncological care is not possible without an intense cooperation with other professions within the University Hospital Motol, such as Surgery Department or the Clinic of Imaging Methods, which offers the latest possibilities for diagnosing and monitoring the effects of treating tumorous diseases. We also cooperate with the Institute of Pathology and Molecular Genetics, which contributes not only to diagnostics, but also to the ability of monitoring the activity of tumorous diseases during and after anti-cancer treatment, all these thanks to the latest methods of molecular genetics. All of these enables the timely detection of disease return. In the area of blood diseases there is a close collaboration with transplantation centers (Internal Clinic I of VFN Prague, Department of Clinical Hematology of the University Hospital Královské Vinohrady and the Institute of Hematology and Blood Transfusion), where our patients are referred if the treatment strategy requires it. We also use services provided by the PET center of the Hospital Na Homolce, which provides our patients with opportunities for special diagnosis and monitoring the effects of treatment for selected diagnoses by means of positron emission tomography (PET).
We also cooperate with patients organizations
The department maintains an active cooperation with such patients organizations as Lymphoma Help and Mamma Help. There is a close collaboration with departments which provide follow-up care, such as rehabilitation centers, centers for psychosomatic medicine, hospices and home nursing, with the goal of ensuring optimum oncological care.